Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis C: allo or autoimmune de novo hepatitis?
about
De novo autoimmune hepatitis in liver transplant: State-of-the-art reviewThe immunoreactive patient: Rejection and autoimmune diseaseImmunological dysfunction during or after antiviral therapy for recurrent hepatitis C reduces graft survivalConcurrent autoimmune hepatitis and grave's disease in hepatitis C during pegylated interferon α-2a and ribavirin therapy.Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation.Strategies to treat interferon-induced graft dysfunction after living donor liver transplantation for hepatitis C.The prediction of immunological dysfunction during antiviral therapy for HCV after liver transplantation: can we improve outcomes?Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrence.Infiltrative (sinusoidal) and hepatitic patterns of injury in acute cellular rejection in liver allograft with clinical implications.Telaprevir versus simeprevir for the treatment of recurrent hepatitis C after living donor liver transplantation.Plasma cell hepatitis induced by the termination of antiviral therapy for recurrent hepatitis C after living donor liver transplantation.De novo autoimmune hepatitis subsequent to switching from type 2b to type 2a alpha-pegylated interferon treatment for recurrent hepatitis C after liver transplantation: report of a case.
P2860
Q26766082-B7A3401E-F4C4-4859-885A-6434D4383829Q26860876-12890827-B76C-4D25-834F-6016C10212D9Q35212334-E788E25C-39C5-43AC-803D-A17C543AFBE4Q35228838-1595FDC0-99F8-4CA1-8F3B-B699C4382575Q37847112-4B4A68EC-053D-43A5-8F8C-6B765AA2C0ABQ40705940-C9E912E2-9622-4100-8FD5-E1FE8A524A8FQ40706786-D62895FD-3084-4784-9093-D4FE7EE69FF9Q41172899-1A3210D5-3142-401A-B135-669F7C93C086Q41530307-AFF6ACB0-A445-4BF0-8585-52944C5D7753Q41652571-575C7F74-32BA-49E1-B0E2-1637F10F1DCBQ50547085-AD1B140E-FA4D-4EA8-8E19-09E75E04921DQ50555761-EB3AE08D-9881-4A52-9CFA-F7E128B5D2F8
P2860
Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis C: allo or autoimmune de novo hepatitis?
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Immune-mediated liver dysfunct ...... autoimmune de novo hepatitis?
@en
Immune-mediated liver dysfunct ...... autoimmune de novo hepatitis?
@nl
type
label
Immune-mediated liver dysfunct ...... autoimmune de novo hepatitis?
@en
Immune-mediated liver dysfunct ...... autoimmune de novo hepatitis?
@nl
prefLabel
Immune-mediated liver dysfunct ...... autoimmune de novo hepatitis?
@en
Immune-mediated liver dysfunct ...... autoimmune de novo hepatitis?
@nl
P2093
P50
P1476
Immune-mediated liver dysfunct ...... autoimmune de novo hepatitis?
@en
P2093
P304
P356
10.1016/J.DLD.2008.09.015
P577
2009-01-21T00:00:00Z